Drugs / Inactivated poliovirus vaccine (IPV)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06748612 | Jan 2025 → Dec 2027 expected | poliomyelitis | International Centre for Diarrhoeal Disease Research, Bangladesh | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated poliovirus vaccine (IPV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06748612 ↗ |
| Modality | Vaccine | “one dose of IPV (0.5 mL) contains inactivated polioviruses to all three poliovirus types: type 1, 2 and 3” NCT06748612 ↗ |